ArticleInternational journal of clinical oncology2024

Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer.

Yang Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.